Clinical research on the therapeutic effect of recombined human endostatin with interventional therapy for hepatic metastatic tumor from gastrointestinal tract

Trial Profile

Clinical research on the therapeutic effect of recombined human endostatin with interventional therapy for hepatic metastatic tumor from gastrointestinal tract

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 May 2012

At a glance

  • Drugs Endostatin (Primary)
  • Indications Gastrointestinal cancer; Liver metastases
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date changed to 31 Dec 2013 as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Actual initiation date 1 Jul 2010 added as reported by Chinese Clinical Trial Register.
    • 21 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top